Overview

Combined Effect of Acitretin and Narrow Band Ultraviolet B on Vitiligo Repigmentation

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Since abnormal keratinocyte (KC) proliferation and differentiation as well as defective E cadherin expression were reported in vitiligo lesions, the investigators set to study the potential efficacy of combining Retinoids, which are known to improve KC proliferation and differentiation and increase the expression of adhesion molecules, with narrowband UVB in the treatment of vitiligo.
Phase:
N/A
Details
Lead Sponsor:
Cairo University
Treatments:
Acitretin